Oruka Therapeutics (ORKA) Shares Outstanding (2010 - 2026)

Oruka Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $10.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) fell 72.07% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (down 72.07% YoY), while the FY2025 annual figure was $9.1 million, down 45.79% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $10.5 million, up from $9.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $37.5 million in Q2 2025, with the low at $1.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $1.2 million (2023), against an average of $8.7 million.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) soared 2998.41% in 2025, then plunged 72.07% in 2026.
• Oruka Therapeutics' Shares Outstanding (Entity) stood at $1.2 million in 2022, then climbed by 0.63% to $1.2 million in 2023, then surged by 1289.41% to $16.8 million in 2024, then tumbled by 45.79% to $9.1 million in 2025, then climbed by 14.88% to $10.5 million in 2026.
• Business Quant data shows ORKA's Shares Outstanding (Entity) at $10.5 million in Q1 2026, $9.1 million in Q4 2025, and $8.8 million in Q3 2025.